Investing.com — Peter C. Farrell，ResMed ...

The home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea ...

Investing.com — ResMed Inc.（NYSE:RMD）的全球总法律顾问Michael J. Rider最近出售了价值约14,263美元的公司股票。根据2024年5月11日采用的预先设立的Rule 10b5-1交易计划，此次交易涉及64股，每股价格为222.86美元。根据 InvestingPro ...

NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is ...

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23 ...